(secondQuint)S.

 Endotoxin, Inflammatory Mediators and MRS Before and After Treatment in MHE.

 60 patients of cirrhosis with Minimal Hepatic Encephalopathy (MHE) who fulfills the inclusion & exclusion criteria will be the part of study.

 Study patients will be divided in to two groups ( n=30 in each group).

 Group L patients will receive lactulose therapy while Group NL will receive placebo.

 After 3 months , S.

endotoxins , inflammatory mediators and MRS will be repeated in each group.

.

 S.

 Endotoxin, Inflammatory Mediators and MRS Before and After Treatment in MHE@highlight

The purpose of this study is to examine S.

endotoxins , inflammatory mediators and Magnetic Resonance Spectroscopy (MRS) before and after treatment in patients of cirrhosis and minimal hepatic encephalopathy.

